238 related articles for article (PubMed ID: 12699350)
1. Vascular and parenchymal mechanisms in multiple drug resistance: a lesson from human epilepsy.
Marroni M; Marchi N; Cucullo L; Abbott NJ; Signorelli K; Janigro D
Curr Drug Targets; 2003 May; 4(4):297-304. PubMed ID: 12699350
[TBL] [Abstract][Full Text] [Related]
2. Drug resistance in epilepsy: expression of drug resistance proteins in common causes of refractory epilepsy.
Sisodiya SM; Lin WR; Harding BN; Squier MV; Thom M
Brain; 2002 Jan; 125(Pt 1):22-31. PubMed ID: 11834590
[TBL] [Abstract][Full Text] [Related]
3. Neuronal and glial expression of the multidrug resistance gene product in an experimental epilepsy model.
Lazarowski A; Ramos AJ; García-Rivello H; Brusco A; Girardi E
Cell Mol Neurobiol; 2004 Feb; 24(1):77-85. PubMed ID: 15049512
[TBL] [Abstract][Full Text] [Related]
4. Expression of the multidrug transporter P-glycoprotein in brain capillary endothelial cells and brain parenchyma of amygdala-kindled rats.
Seegers U; Potschka H; Löscher W
Epilepsia; 2002 Jul; 43(7):675-84. PubMed ID: 12102668
[TBL] [Abstract][Full Text] [Related]
5. Significance of MDR1 and multiple drug resistance in refractory human epileptic brain.
Marchi N; Hallene KL; Kight KM; Cucullo L; Moddel G; Bingaman W; Dini G; Vezzani A; Janigro D
BMC Med; 2004 Oct; 2():37. PubMed ID: 15473912
[TBL] [Abstract][Full Text] [Related]
6. Do ATP-binding cassette transporters cause pharmacoresistance in epilepsy? Problems and approaches in determining which antiepileptic drugs are affected.
Löscher W; Luna-Tortós C; Römermann K; Fedrowitz M
Curr Pharm Des; 2011; 17(26):2808-28. PubMed ID: 21827408
[TBL] [Abstract][Full Text] [Related]
7. Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier.
Rao VV; Dahlheimer JL; Bardgett ME; Snyder AZ; Finch RA; Sartorelli AC; Piwnica-Worms D
Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3900-5. PubMed ID: 10097135
[TBL] [Abstract][Full Text] [Related]
8. A Novel Approach to Refractory Epilepsy by Targeting Pgp Peripherally and Centrally: Therapeutic Targets and Future Perspectives.
Langeh U; Chawla P; Gupta GD; Singh S
CNS Neurol Disord Drug Targets; 2020; 19(10):741-749. PubMed ID: 32814543
[TBL] [Abstract][Full Text] [Related]
9. ABC transporters during epilepsy and mechanisms underlying multidrug resistance in refractory epilepsy.
Lazarowski A; Czornyj L; Lubienieki F; Girardi E; Vazquez S; D'Giano C
Epilepsia; 2007; 48 Suppl 5():140-9. PubMed ID: 17910594
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of multiple drug resistance genes in endothelial cells from patients with refractory epilepsy.
Dombrowski SM; Desai SY; Marroni M; Cucullo L; Goodrich K; Bingaman W; Mayberg MR; Bengez L; Janigro D
Epilepsia; 2001 Dec; 42(12):1501-6. PubMed ID: 11879359
[TBL] [Abstract][Full Text] [Related]
11. MDR1 gene expression in brain of patients with medically intractable epilepsy.
Tishler DM; Weinberg KI; Hinton DR; Barbaro N; Annett GM; Raffel C
Epilepsia; 1995 Jan; 36(1):1-6. PubMed ID: 8001500
[TBL] [Abstract][Full Text] [Related]
12. The drug-transporter gene MDR1 C3435T and G2677T/A polymorphisms and the risk of multidrug-resistant epilepsy in Turkish children.
Seven M; Batar B; Unal S; Yesil G; Yuksel A; Guven M
Mol Biol Rep; 2014 Jan; 41(1):331-6. PubMed ID: 24213830
[TBL] [Abstract][Full Text] [Related]
13. Drug resistance in epilepsy: the role of the blood-brain barrier.
Abbott NJ; Khan EU; Rollinson CM; Reichel A; Janigro D; Dombrowski SM; Dobbie MS; Begley DJ
Novartis Found Symp; 2002; 243():38-47; discussion 47-53, 180-5. PubMed ID: 11990780
[TBL] [Abstract][Full Text] [Related]
14. Distribution and functional activity of P-glycoprotein and multidrug resistance-associated proteins in human brain microvascular endothelial cells in hippocampal sclerosis.
Kubota H; Ishihara H; Langmann T; Schmitz G; Stieger B; Wieser HG; Yonekawa Y; Frei K
Epilepsy Res; 2006 Mar; 68(3):213-28. PubMed ID: 16361082
[TBL] [Abstract][Full Text] [Related]
15. Drug resistance in epilepsy: human epilepsy.
Sisodiya SM; Lint WR; Harding BN; Squier MV; Thom M
Novartis Found Symp; 2002; 243():167-74; discussion 174-9, 180-5. PubMed ID: 11990775
[TBL] [Abstract][Full Text] [Related]
16. Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells.
Stein U; Lage H; Jordan A; Walther W; Bates SE; Litman T; Hohenberger P; Dietel M
Int J Cancer; 2002 Feb; 97(6):751-60. PubMed ID: 11857350
[TBL] [Abstract][Full Text] [Related]
17. Transient increase of P-glycoprotein expression in endothelium and parenchyma of limbic brain regions in the kainate model of temporal lobe epilepsy.
Seegers U; Potschka H; Löscher W
Epilepsy Res; 2002 Oct; 51(3):257-68. PubMed ID: 12399076
[TBL] [Abstract][Full Text] [Related]
18. Development of a humanized in vitro blood-brain barrier model to screen for brain penetration of antiepileptic drugs.
Cucullo L; Hossain M; Rapp E; Manders T; Marchi N; Janigro D
Epilepsia; 2007 Mar; 48(3):505-16. PubMed ID: 17326793
[TBL] [Abstract][Full Text] [Related]
19. Multidrug resistance in epilepsy: rats with drug-resistant seizures exhibit enhanced brain expression of P-glycoprotein compared with rats with drug-responsive seizures.
Volk HA; Löscher W
Brain; 2005 Jun; 128(Pt 6):1358-68. PubMed ID: 15716304
[TBL] [Abstract][Full Text] [Related]
20. Potential role of drug transporters in the pathogenesis of medically intractable epilepsy.
Kwan P; Brodie MJ
Epilepsia; 2005 Feb; 46(2):224-35. PubMed ID: 15679503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
